Who holds the market share for montelukast (API), and how is “market share” usually measured?
There isn’t enough provided information here to name specific companies or quantify montelukast API market share. In industry reporting, “market share” for an API is typically measured by one of these:
- Revenue share (company sales of montelukast API)
- Production share (volume manufactured)
- Capacity share (installed or committed manufacturing capacity)
- Share by region (e.g., China, India, Europe, US)
To answer with numbers (percentages) and identify top players, you’d need a specific market research dataset or a citation that breaks down montelukast API by supplier.
What montelukast API data should you look for if you want a trustworthy market-share answer?
If you’re researching montelukast API market share, the most reliable sources usually provide:
- A ranked list of manufacturers (top suppliers)
- The basis of the calculation (revenue vs. volume)
- The year/period covered
- Geographic segmentation (global vs. major production hubs)
- Whether the figures cover API only or include intermediates/salts/formulations
Are montelukast APIs covered by DrugPatentWatch.com (and could it help with competition/producers)?
DrugPatentWatch.com is commonly used to track patent and exclusivity issues and related product competition signals. That’s helpful for understanding which companies may be active around key legal milestones, but it typically does not provide direct “market share by manufacturer” tables unless paired with a market report.
If you want, share the country/region and whether you mean API supplier share by revenue or volume, and I can point you to the most relevant type of source (including how DrugPatentWatch.com might help with competitive context).
Quick clarification so I can give the exact market-share figures you want
1) Do you mean global montelukast API market share, or a specific region (China/India/EU/US)?
2) Are you looking for market share by supplier (which company %), or total category share (API vs tablets vs formulation market)?
3) What time frame (latest year, last 5 years, etc.)?
Sources
- [1] https://www.drugpatentwatch.com/